CEO Jim Brown highlighted that "USANA delivered positive second quarter results consistent with our internal expectations. Consolidated net sales grew 11% year-over-year and adjusted earnings per ...

Management anticipates near-term margin pressure from "meaningful" investment in the global convention, new product introductions, and the compensation plan rollout, all of which are expected to ...

USANA Health faces declining core direct-selling revenues, offset only by the recent Hiya acquisition, which brings lower ...

USANA Health Sciences, Inc. (NYSE: USNA) today announced preliminary results for the third quarter ended September 27, 2025. The Company anticipates third quarter 2025 net sales will be approximately ...

Operator: Good morning, and welcome to the USANA Health Sciences Second Quarter Earnings Call. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference ...

USANA Health Sciences, Inc. (NYSE:USNA) (“the Company,” “USANA”) today announced that it has updated the timing of the release of its third quarter 2025 financial results, which had previously been ...